Top Consumer Driven Health Care Stories
CVS makes a case for its pricey megadeal
By Max NisenCVS's already costly deal looks even more expensive after its warning on Thursday of a possible profit decline this year, despite an expected $1.2 billion benefit from tax cuts. CVS shares fell though it reported positive quarterly results.
